Ligand Pharmaceuticals Inc - Significant Ownership

Signature - Title
/s/ Octavio Espinoza - Octavio Espinoza, Chief Financial Officer
Location
San Diego, CA
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Ligand Pharmaceuticals Inc.

Significant Ownership of Ligand Pharmaceuticals Inc

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
PELTHOS THERAPEUTICS INC. Common Stock, par value $0.0001 per share 49.9% 4.93M Ligand Pharmaceuticals Incorporated Jul 1, 2025

Schedules 13D/G Reported by Ligand Pharmaceuticals Inc:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Date Filed
* An asterisk sign (*) next to the price indicates that the price is likely invalid.